ADH5 and neurodegenerative disease: Based on the evidence that GSNOR deficiency results in ageing-related phenotypes and that brain represents the organ mostly affected during ageing, here we have aimed at characterizing the role of GSNOR in modulating the severity of two neurodegenerative diseases, PD and fALS, taking SH-SY5Y as elective experimental system.